학술논문
T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial.
Document Type
Article
Author
Sureda‐Balari, Anna; Terol, M. José; Domingo‐Domènech, Eva; Rodriguez, Ana Pilar González; Mohedo, Francisca Hernández; Céspedes, Javier Núñez; De La Cruz Vicente, Fátima; Muñoz, Carmen Martínez; Díaz, M. Elena Amutio; Córdoba, Raul; Izquierdo, Antonia Rodríguez; Domínguez, Samuel Romero; Meijide, Javier Briones; Greil, Richard; Velázquez, Miriam Moreno; Rubio, Araceli; Oteiro, Mariana Bastos; Gómez, Pilar; Avivi, Irit; Casanova, María
Source
HemaSphere; 2022 Supplement, Vol. 6, p45-45, 1p
Subject
Language
ISSN
25729241